EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria

Olga Pustotina, Samuel H Myers, Vittorio Unfer, Irina Rasulova

Gynecologic and Obstetric Investigation · 2024 · 89 (2) · 131-139

DOI: 10.1159/000536163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, online erschienen am 31.01.2024. Verfasst von Olga Pustotina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology with Reproductive Medicine, F.I. Inozemtsev Academy of Medical Education, Saint Petersburg, Russian Federatio…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Insulin Resistance. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Setting

Insulin resistance (IR) and compensatory hyperinsulinemia are considered contributing factors toward polycystic ovary syndrome (PCOS).

Objectives

This study evaluates the frequency of metabolic abnormalities in PCOS patients and the effects of myo-inositol (MI) and D-chiro-inositol (DCI), in a 40:1 ratio on hormonal and metabolic parameters.

Participants

Thirty-four women with PCOS phenotype A (endocrine-metabolic syndrome [EMS-type 1]) between the ages of 20–40.

Design

Open prospective study with phenotype A (EMS-type I, n = 34) supplemented with 2,255 mg/day of inositol (MI and DCI in a 40:1 ratio) for 3 months.

Methods

The following were measured before and after treatment: serum levels of follicular stimulating hormone, luteinizing hormone (LH), estradiol, total and free testosterone, sex hormone-binding globulin (SHBG), free androgen index (FAI), anti-Müllerian hormone, glucose, insulin, HOMA-IR, and body mass index (BMI).

Results

55.9% of the enrolled patients were overweight or obese, 50% affected by IR, 17.6% with a history of gestational diabetes mellitus, and 61.8% had familial diabetes mellitus. At the conclusion of the study, BMI (p = 0.0029), HOMA-IR (p < 0.001) significantly decreased, along with decreased numbers of patients with elevated insulin levels. The supplementation resulted in decreased total testosterone (p < 0.001), free testosterone (p < 0.001), FAI (p < 0.001), and LH (p < 0.001); increased SHBG (p < 0.001) and estradiol (p < 0.001).

Limitations

The present analysis was limited to a 12-week follow-up, which precluded a long-term evaluation of the effects of MI and DCI combination. Also, this period was insufficient to achieve and analyze clinical changes such as restoration of the menstrual cycle, restoration of reproductive function, and clinical manifestations of hyperandrogenism.

Conclusions

Supplementation improved metabolic and hormonal profile in PCOS phenotype A (EMS-type I) patients. This builds upon previous work that demonstrated that combined inositol treatment may be effective in PCOS. The study presented herein, used a reduced concentration than in prior literature; however, a significant change in hormonal and metabolic parameters was still observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeInsulin ResistanceFemaleHumansYoung AdultAdultInositolProspective StudiesLuteinizing HormoneInsulinEstradiolTestosteronePhenotypeMetabolome

Stichwörter der Autor:innen

D-chiro-inositolInsulin resistanceMyo-inositolPolycystic ovarian syndrome

Substanzen

InositolLuteinizing HormoneInsulinEstradiolTestosterone

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology with Reproductive Medicine, F.I. Inozemtsev Academy of Medical Education, Saint Petersburg, Russian Federation.
  • Lo.Li Pharma, Rome, Italy.
  • UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy.
  • LCC "H-Clinic", Moscow, Russian Federation.

Zitieren

APA

Pustotina, O., Myers, S. H., Unfer, V., & Rasulova, I. (2024). The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria. Gynecologic and Obstetric Investigation, 89(2), 131-139. https://doi.org/10.1159/000536163

Vancouver

Pustotina O, Myers SH, Unfer V, Rasulova I. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria. Gynecologic and Obstetric Investigation. 2024;89(2):131-139. doi:10.1159/000536163

BibTeX
@article{Pustotina2024,
  author = {Pustotina, Olga and Myers, Samuel H and Unfer, Vittorio and Rasulova, Irina},
  title = {The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria},
  journal = {Gynecologic and Obstetric Investigation},
  year = {2024},
  volume = {89},
  number = {2},
  pages = {131--139},
  doi = {10.1159/000536163}
}
Kostenlos starten →